Pembrolizumab, 25 mg

Pembrolizumab is an established chemical intermediate, identified as a monoclonal antibody. Its molecular formula is C245H383N443O153S6, with a molecular weight of approximately 50,000 daltons. This compound belongs to the immunoglobulin superfamily, specifically IgG4 kappa subclass. It is offered in a pure form, with a specified purity level of 98%. This particular batch comes in a pack size of 25 mg. Pembrolizumab is primarily used in cancer treatment, particularly for melanoma and non-small cell lung cancer. Additionally, it has demonstrated selectivity towards PD-1 receptors, making it a valuable tool in immune checkpoint inhibition therapy.

• CAS Number: 1374853-91-4